Understanding and Treatment of Infantile Nystagmus Syndrome

Download Report

Transcript Understanding and Treatment of Infantile Nystagmus Syndrome

Understanding and Treatment of Infantile Nystagmus Syndrome

Richard W. Hertle, MD, FAAO, FACS, FAAP Chief of Pediatric Ophthalmology, Children’s Hospital of Pittsburgh Director of Ocular Motility, The UPMC Eye Center Professor of Ophthalmology, The University of Pittsburgh The Laboratory of Visual and Ocular Motor Neurophysiology

Examination Techniques: Highlights

• • • • •

Acuity

Binocular and Monocular

Gaze-Dependent

Color, Contrast Ocular Motor

Strabismus

Nystagmus – “nulls”

Head Posture

Accommodation Refraction

Objective

Visual Acuity Testing

20/400 20/200 20/100 20/50 20/25

Evaluation Techniques: Afferent System

Vision testing procedures

   

Behavioral Vision Testing (acuity, color, stereo) Visual Evoked Responses (flash, pattern, sweep) Electroretinography (flash, pattern) Contrast, Color and Visual Field Testing

Evaluation: Efferent System Eye Movement Recordings

Methods

High speed photographic methods.

“Contact” electrooculography.

Infrared reflectance oculography.

Scleral contact lens/magnetic search coils.

Eye Movement Recordings

• •

Diagnosis/Differentiation of Eye Movement Disorders.

Utility as an “Outcome Measure” in Clinical Research.

Deg R L

10

Deg

0 5 -5 0 1 Foveation Periods Within ±..5° by ±4°/sec Window 2 Time (sec) 3 4 5

Eye Movement Recordings

Age Distribution Value of data

Diagnosis.

Classification.

Etiology.

Therapy.

Research.

30% 25% 20% 15% 10% 5% 0% <2

685 Patients 1998-2005

<5 <10 <15

Age (year)

<20 <30 >31

Afferent System Conception Development Birth Infancy Efferent System

Vision Vergence, Versions STABLE OCULAR MOTOR SYSTEM

CEMAS

Disease Name Criteria INFANTILE NYSTAGMUS SYNDROME (INS) [Old Congenital Nystagmus and “Motor and Sensory” Nystagmus]

Infantile onset, ocular motor recordings show diagnostic (accelerating) slow phases

Common Associated Findings General Comments

Conjugate, horizontal-torsional, increases with fixation attempt, progression from pendular to jerk, family history often positive, constant, conjugate, with or without associated sensory system deficits (e.g., albinism, achromatopsia), associated strabismus or refractive error, decreases with convergence, null and neutral zones present, associated head posture or head shaking, may exhibit a ”latent” component, “reversal” with OKN stimulus or (a)periodicity to the oscillation. Candidates on Chromosome X and 6 May decrease with induced convergence, increased fusion, extraocular muscle surgery, contact lenses and sedation.

Waveforms may change in early infancy, head posture usually evident by 4 years of age. Vision prognosis dependent on integrity of sensory system.

Nystagmus and Vision

“Sensory” System

       

Refractive Error Amblyopia Abnormal Binocular Vision Ocular Media Damage Retinal Disease Nycloptia/Photophobia Optic Nerve Disease Visual Cortex Disease

“Motor” System

   

Oscillation Strabismus Abnormal Pursuit (tracking) Abnormal Saccades (fast eye movements)

“MOTOR” SYSTEM TREATMENT

Medications

Visual Training (strabismus, binocular dysfunction)

Acupuncture

Biofeedback

Vibratory Stimulation

Prisms, Telescopes, Contact Lenses

Botox

Eye Muscle Surgery

Medical Treatments

Spectacles

Contact Lenses

Low Vision Aids

Penalization (patching, drops)

Medical Treatments

 

Photophobia Nystagmus

• Sedatives, Hypnotics, Neuroleptics, Anti-seizure drugs • Acupuncture, Biofeedback, Vibratory Stimulation 

Strabismus and binocular dysfunction

• Orthoptics • Spectacles • Penalization

“Nystagmus” Surgery

• •

Effect a Positive Change on the Oscillation

Improve Waveform

Increase Foveation

Broaden Null Position

Improve Periodicity Treat Anomalous Head Positions

ANIMAL MODEL OF INS

• • • • •

Achiasmatic Belgian Sheepdogs Ocular Motor Behavior Ocular Motor Analysis Infrared Oculography Recording Preoperative and Postoperative

 

Visual Behavior Eye Movement Recordings

• • •

HUMAN CLINICAL TRIALS EYE MUSCLE SURGERY AND INS Simple tenotomy of all 4 horizontal recti Reattachment at the original insertion Final Effect related to underlying visual system disease Hertle RW

, Dell’Osso LF, FitzGibbon, EJ, Yang D, Mellow SD. Horizontal Rectus Muscle Tenotomy In Children with Infantile Nystagmus Syndrome: A Pilot Study.

Journal of AAPOS 2004:8;539-548

Hertle RW

, Dell’Osso LF, FitzGibbon, EJ, Thompson DJS, Yang D, Mellow S. Horizontal Rectus Tenotomy In Patients with Congenital Nystagmus: Results In Ten Adults Ophthalmology 2003:11;2097-2115

HUMAN CLINICAL TRIALS EYE MUSCLE SURGERY AND INS Increased Foveation (amount of time during a beat of INS during which the eye is moving at <4 deg/sec and within a few degrees of the target – when the eye/brain “sees”) t Targe Preferred OD Fixing Under Binocular Conditions t Targe

HUMAN CLINICAL TRIALS EYE MUSCLE SURGERY AND INS Improved Waveforms (Pure Jerk and Pendular to Jerk/Pendular with foveation) Target Preferred OD Fixing Under Binocular Conditions Target

HUMAN CLINICAL TRIALS EYE MUSCLE SURGERY AND INS

Increased Breadth of The Null Zone 10 degrees 5 sec R L 10 degrees 5 sec Pre-Operative R L Post-Operative

HUMAN CLINICAL TRIALS EYE MUSCLE SURGERY AND INS

1-3 Lines of Recognition Acuity Increase Pre-Post Tenotomy Acuity 1 0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient #

LogMar OU Pre LogMar OU Post

HUMAN CLINICAL TRIALS EYE MUSCLE SURGERY AND INS

Improved Visual Recognition Time (Speed of Recognition) 10 00 Lo gM A R 0.94 (20/176, S ize 7) 8 00 6 00 4 00 -40 -30 -2 0 -1 0 0 1 0 20 V e lo city (d e gre e s/s ec ) 3 0 4 0

GAZE DEPENDENT VISUAL ACUITY 30 deg 20 deg 10 deg E F P 0 deg 10 deg 20 deg 30 deg

Fig. 1.Gaze angle

HUMAN CLINICAL TRIALS EYE MUSCLE SURGERY AND INS

Improved Gaze Dependent Visual Acuity (GDVA) PRE-POST GDVA PT. 19

1 0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

0 -30 -20 -10 0 10

DEGREES OF GAZE

20 30 PREOP POSTOP

PRE-POST GDVA PT. 25

1 0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

0 -30 -20 -10 0 10

DEGREES OF GAZE

20 30 PREOP POSTOP

Enthesial Area Annulus Of Zinn “Myotendon”

Myelin Axon 2u CONTROL HUMAN ENTHESIS Nerve Ending Capillary 500u 2u

TREATMENT:ANIMAL MODEL

Etiologic

INS with Gene Defect (RPE65 – Leber’s in Humans)

Genetic Therapy*

Conclusions Ask For:

• • • • •

Accurate Evaluation

 

Afferent System Efferent System Accurate Diagnosis

   

Sensory System Deficits Nystagmus Type Strabismus Head Posturing Medical Treatment Options Surgical Treatment Options Treatment versus “CURE”